Literature DB >> 14981755

Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.

K H Wong1, Y M Liu, P S P Ng, B W Y Young, S S Lee.   

Abstract

Current epidemiology of hepatitis A virus (HAV) and hepatitis E virus (HEV) in Hong Kong was evaluated in 936 adult Chinese subjects recruited through a telephone interview in 2001. Some 15% of the subjects had IgG antibodies to both HAV and HEV while 665 (71.0%) and 176 (18.8%) had anti-HAV and anti-HEV, respectively. Age was the most significant independent factor. Six hundred thirty-eight (79.8%) and 165 (20.7%) subjects aged > or =30 had anti-HAV and anti-HEV, respectively, as compared with 27 (19.7%) and 11 (8.0%) in people aged <30. The corresponding adjusted Odds ratio (OR) was 14.94 (95% CI: 9.13-24.44; P<0.001) for anti-HAV positivity and 2.99 (95% CI: 1.58-5.67; P=0.001) for anti-HEV positivity. Subjects born outside Hong Kong were more likely to have anti-HAV (adjusted OR: 3.41; 95% CI: 2.21-5.26; P<0.001) but not anti-HEV. Non-labour work people were less likely to have anti-HAV-adjusted OR, 0.40 (95% CI: 0.26-0.62; P<0.001). Age-specific HAV prevalence right shifted in the last 20 years. Anti-HAV positivity was less frequent, across all age groups, in subjects >21-years-old in the present study than another study done in 1987-89 (P<0.001). HAV prevalence only increased slightly in every 10-year age groups of people aged 21-50 when compared with their corresponding 10-year-younger age groups (P=0.11), suggesting an ageing cohort effect with no major infections in the last decade. For HEV, both the overall and age-specific prevalence decreased over the last decade (P<0.001). The increasing proportion of susceptible population to enterically transmitted viral hepatitis has implications to future prevention and control programmes, including vaccination strategies. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14981755     DOI: 10.1002/jmv.20040

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  16 in total

1.  Forecasting model for the incidence of hepatitis A based on artificial neural network.

Authors:  Peng Guan; De-Sheng Huang; Bao-Sen Zhou
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

2.  Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt.

Authors:  Salwa S Seif Eldin; Ismail Seddik; Enas A Daef; M T Shata; Marwa Raafat; Laila Abdel Baky; M A Nafeh
Journal:  Egypt J Immunol       Date:  2010

3.  Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain.

Authors:  Maria Buti; Angela Domínguez; Pere Plans; Rossend Jardí; Mélani Schaper; Jordi Espuñes; Neus Cardeñosa; Francisco Rodríguez-Frías; Rafael Esteban; Antoni Plasència; Luis Salleras
Journal:  Clin Vaccine Immunol       Date:  2006-10-18

4.  Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A.

Authors:  H R Dalton; W Stableforth; S Hazeldine; P Thurairajah; R Ramnarace; U Warshow; S Ijaz; V Ellis; R Bendall
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-26       Impact factor: 3.267

5.  Etiological investigation of fatal liver failure during the course of chronic hepatitis B in southeast China.

Authors:  Wei-Min Ke; Xue-Jun Li; Li-Na Yu; Jing Lai; Xiao-He Li; Zhi-Liang Gao; Pei-Jia Chen
Journal:  J Gastroenterol       Date:  2006-04       Impact factor: 6.772

6.  Racial differences in seroprevalence of HAV and HEV in blood donors in the Western Cape, South Africa: a clue to the predominant HEV genotype?

Authors:  T Lopes; R Cable; C Pistorius; T Maponga; S Ijaz; W Preiser; R Tedder; M I Andersson
Journal:  Epidemiol Infect       Date:  2017-03-30       Impact factor: 4.434

7.  Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein.

Authors:  Deepak Sehgal; Saijo Thomas; Mahua Chakraborty; Shahid Jameel
Journal:  Virol J       Date:  2006-05-26       Impact factor: 4.099

8.  Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A.

Authors:  Arni S R Srinivasa Rao; Maggie H Chen; Ba' Z Pham; Andrea C Tricco; Vladimir Gilca; Bernard Duval; Murray D Krahn; Chris T Bauch
Journal:  BMC Infect Dis       Date:  2006-12-05       Impact factor: 3.090

9.  Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas.

Authors:  Mélanie Caron; Mirdad Kazanji
Journal:  Virol J       Date:  2008-12-22       Impact factor: 4.099

10.  Genotype distribution and sequence variation of hepatitis E virus, Hong Kong.

Authors:  Wai Yip Lam; Rickjason C W Chan; Joseph J Y Sung; Paul K S Chan
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.